Immutep (IMMP) Return on Sales (2016 - 2025)
Historic Return on Sales for Immutep (IMMP) over the last 11 years, with Q2 2025 value amounting to 13.09%.
- Immutep's Return on Sales fell 25005700.0% to 13.09% in Q2 2025 from the same period last year, while for Jun 2025 it was 18.13%, marking a year-over-year decrease of 25056100.0%. This contributed to the annual value of 5.95% for FY2025, which is 5000.0% down from last year.
- According to the latest figures from Q2 2025, Immutep's Return on Sales is 13.09%, which was down 25005700.0% from 3251.28% recorded in Q4 2024.
- In the past 5 years, Immutep's Return on Sales registered a high of 2346985037513345.0% during Q4 2022, and its lowest value of 72618336207647.02% during Q4 2021.
- In the last 5 years, Immutep's Return on Sales had a median value of 3251.28% in 2024 and averaged 841055820827788.1%.
- As far as peak fluctuations go, Immutep's Return on Sales soared by 2000000000bps in 2022, and later tumbled by 2000000000bps in 2024.
- Over the past 5 years, Immutep's Return on Sales (Quarter) stood at 72618336207647.02% in 2021, then skyrocketed by 3332bps to 2346985037513345.0% in 2022, then dropped by -6bps to 2207141455170220.2% in 2023, then tumbled by -100bps to 3251.28% in 2024, then plummeted by -100bps to 13.09% in 2025.
- Its Return on Sales stands at 13.09% for Q2 2025, versus 3251.28% for Q4 2024 and 2487.48% for Q2 2024.